Cargando…
Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives
An estimated 990,000 new cases of gastric cancer are diagnosed worldwide each year. Surgical excision, the only chance for prolonged survival, is feasible in about 20% of cases. Even after surgery, the median survival is limited to 12 to 20 months due to the frequency of locoregional and/or metastat...
Autores principales: | Schernberg, A., Rivin del Campo, E., Rousseau, B., Matzinger, O., Loi, M., Maingon, P., Huguet, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008627/ https://www.ncbi.nlm.nih.gov/pubmed/29928701 http://dx.doi.org/10.1016/j.ctro.2018.02.005 |
Ejemplares similares
-
Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2017) -
Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation
por: Gorphe, Philippe, et al.
Publicado: (2017) -
Challenges in the Study of Adjuvant Chemoradiation After Pancreaticoduodenectomy
por: Crane, Christopher H., et al.
Publicado: (2009) -
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward
por: Papadimitriou, Konstantinos, et al.
Publicado: (2015) -
Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
por: Hadzitheodorou, Christina, et al.
Publicado: (2017)